Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARVIND REMEDIES vs WINDLAS BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ARVIND REMEDIES WINDLAS BIOTECH ARVIND REMEDIES/
WINDLAS BIOTECH
 
P/E (TTM) x -0.2 32.9 - View Chart
P/BV x - 4.5 - View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ARVIND REMEDIES   WINDLAS BIOTECH
EQUITY SHARE DATA
    ARVIND REMEDIES
Jun-15
WINDLAS BIOTECH
Mar-24
ARVIND REMEDIES/
WINDLAS BIOTECH
5-Yr Chart
Click to enlarge
High Rs66590 11.2%   
Low Rs10226 4.4%   
Sales per share (Unadj.) Rs115.5303.3 38.1%  
Earnings per share (Unadj.) Rs-47.028.0 -167.9%  
Cash flow per share (Unadj.) Rs-42.634.4 -123.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs-6.2214.0 -2.9%  
Shares outstanding (eoy) m68.1420.80 327.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.31.3 24.5%   
Avg P/E ratio x-0.814.6 -5.5%  
P/CF ratio (eoy) x-0.911.9 -7.5%  
Price / Book Value ratio x-6.11.9 -321.3%  
Dividend payout %019.7 -0.0%   
Avg Mkt Cap Rs m2,5918,490 30.5%   
No. of employees `000NANA-   
Total wages/salary Rs m160875 18.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,8716,310 124.7%  
Other income Rs m59135 43.5%   
Total revenues Rs m7,9296,444 123.0%   
Gross profit Rs m-2,306782 -295.0%  
Depreciation Rs m295134 219.2%   
Interest Rs m71111 6,431.7%   
Profit before tax Rs m-3,253771 -421.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-52189 -27.7%   
Profit after tax Rs m-3,200582 -550.0%  
Gross profit margin %-29.312.4 -236.5%  
Effective tax rate %1.624.5 6.6%   
Net profit margin %-40.79.2 -440.9%  
BALANCE SHEET DATA
Current assets Rs m5,0014,313 116.0%   
Current liabilities Rs m5,9181,718 344.6%   
Net working cap to sales %-11.741.1 -28.3%  
Current ratio x0.82.5 33.6%  
Inventory Days Days4106 3.7%  
Debtors Days Days2,21479 2,808.9%  
Net fixed assets Rs m2,8371,943 146.0%   
Share capital Rs m681104 655.2%   
"Free" reserves Rs m-1,1044,346 -25.4%   
Net worth Rs m-4234,450 -9.5%   
Long term debt Rs m1,9380-   
Total assets Rs m7,8386,256 125.3%  
Interest coverage x-3.670.8 -5.1%   
Debt to equity ratio x-4.60-  
Sales to assets ratio x1.01.0 99.6%   
Return on assets %-31.89.5 -335.2%  
Return on equity %757.013.1 5,790.1%  
Return on capital %-167.817.6 -955.1%  
Exports to sales %0.30-   
Imports to sales %00-   
Exports (fob) Rs m27NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27313 8.5%   
Fx outflow Rs m075 0.0%   
Net fx Rs m27238 11.2%   
CASH FLOW
From Operations Rs m-1,5121,090 -138.7%  
From Investments Rs m1,050-921 -114.1%  
From Financial Activity Rs m439-153 -287.1%  
Net Cashflow Rs m-2316 -140.4%  

Share Holding

Indian Promoters % 3.6 62.5 5.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.6 0.2%  
FIIs % 0.0 2.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 96.4 37.5 257.2%  
Shareholders   71,277 45,706 155.9%  
Pledged promoter(s) holding % 55.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ARVIND REMEDIES With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ARVIND REMEDIES vs WINDLAS BIOTECH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ARVIND REMEDIES vs WINDLAS BIOTECH Share Price Performance

Period ARVIND REMEDIES WINDLAS BIOTECH S&P BSE HEALTHCARE
1-Day -4.86% 4.01% 1.23%
1-Month -10.82% 1.40% -0.24%
1-Year -64.58% 118.07% 43.62%
3-Year CAGR -45.48% 50.76% 20.35%
5-Year CAGR -32.03% 18.80% 26.24%

* Compound Annual Growth Rate

Here are more details on the ARVIND REMEDIES share price and the WINDLAS BIOTECH share price.

Moving on to shareholding structures...

The promoters of ARVIND REMEDIES hold a 3.6% stake in the company. In case of WINDLAS BIOTECH the stake stands at 62.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ARVIND REMEDIES and the shareholding pattern of WINDLAS BIOTECH.

Finally, a word on dividends...

In the most recent financial year, ARVIND REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

WINDLAS BIOTECH paid Rs 5.5, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of ARVIND REMEDIES, and the dividend history of WINDLAS BIOTECH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.